224 related articles for article (PubMed ID: 19474508)
1. Cardiac resynchronization therapy with and without implantable cardioverter-defibrillator.
Shimizu A
Circ J; 2009 Jun; 73 Suppl A():A29-35. PubMed ID: 19474508
[TBL] [Abstract][Full Text] [Related]
2. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
[TBL] [Abstract][Full Text] [Related]
3. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure.
Woo CY; Strandberg EJ; Schmiegelow MD; Pitt AL; Hlatky MA; Owens DK; Goldhaber-Fiebert JD
Ann Intern Med; 2015 Sep; 163(6):417-26. PubMed ID: 26301323
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
9. Dyssynchrony and the risk of ventricular arrhythmias.
Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
[TBL] [Abstract][Full Text] [Related]
10. Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.
Zeitler EP; Friedman DJ; Daubert JP; Al-Khatib SM; Solomon SD; Biton Y; McNitt S; Zareba W; Moss AJ; Kutyifa V
J Am Coll Cardiol; 2017 May; 69(19):2369-2379. PubMed ID: 28494974
[TBL] [Abstract][Full Text] [Related]
11. Are changes in the extent of left ventricular dyssynchrony as assessed by speckle tracking associated with response to cardiac resynchronization therapy?
Ghani A; Delnoy PP; Ottervanger JP; Ramdat Misier AR; Smit JJ; Adiyaman A; Elvan A
Int J Cardiovasc Imaging; 2016 Apr; 32(4):553-61. PubMed ID: 26585749
[TBL] [Abstract][Full Text] [Related]
12. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
[TBL] [Abstract][Full Text] [Related]
14. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
[TBL] [Abstract][Full Text] [Related]
15. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
[TBL] [Abstract][Full Text] [Related]
17. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.
McAlister FA; Ezekowitz J; Hooton N; Vandermeer B; Spooner C; Dryden DM; Page RL; Hlatky MA; Rowe BH
JAMA; 2007 Jun; 297(22):2502-14. PubMed ID: 17565085
[TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy: who benefits?
Chinitz JS; d'Avila A; Goldman M; Reddy V; Dukkipati S
Ann Glob Health; 2014; 80(1):61-8. PubMed ID: 24751566
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular lead placement in cardiac resynchronization therapy: where and how?
Khan FZ; Virdee MS; Fynn SP; Dutka DP
Europace; 2009 May; 11(5):554-61. PubMed ID: 19372115
[TBL] [Abstract][Full Text] [Related]
20. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
